Company Data

Cartesian Therapeutics Inc.

Ticker
RNAC
Current Price
$19.52 -0.76%
Market Cap
$496.1M
Price Target
Refer to Report
Volume
77.4K
52wk Range
$11.665 - $41.87
Advanced Market Data

Overview

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy